Thromboangiitis obliterans plasma-derived exosomal miR-223-5p inhibits cell viability and promotes cell apoptosis of human vascular smooth muscle cells by targeting VCAM1

• Published in: Annals of medicine (Helsinki) 2021-01, Vol.53 (1), p.1130-1142
• Main Authors: Deng, Ying, Tong, Jindong, Shi, Weijun, Tian, Zhongyi, Yu, Bo, Tang, Jingdong
• Format: Article
• Language: English
• Subjects: Apoptosis; bioinformatics analysis; Cardiology & Cardiovascular Disorders; cell apoptosis; Cell Survival; Circulating exosomal miRNAs; Computational Biology; exosomes; Exosomes - genetics; Exosomes - metabolism; Humans; MicroRNAs - genetics; MicroRNAs - metabolism; Muscle, Smooth, Vascular - metabolism; Thromboangiitis Obliterans - blood; Thromboangiitis Obliterans - genetics; Up-Regulation; vascular smooth muscle cells
• ISSN: 0785-3890; 1365-2060
• DOI: 10.1080/07853890.2021.1949487

Background: Exosomes-encapsulated microRNAs (miRNAs) have been established to be implicated in the pathogenesis of different diseases. Nevertheless, circulating exosomal miRNAs of thromboangiitis obliterans (TAO) remains poorly understood. This study aimed to explore the effects of exosomal miRNAs associated with TAO on human vascular smooth muscle cells (HVSMCs). Methods: The exosomes were isolated from the plasma of TAO patients and normal controls and then were sent for small RNA sequencing. Differentially expressed miRNAs (DE-miRNAs) were identified by bioinformatics analysis and were confirmed by RT-qPCR. After that, PKH67 staining was used to label exosomes and co-cultured with HVSMCs. Cell viability and apoptosis were, respectively, tested by CCK-8 assay and flow cytometry. Finally, dual-luciferase reporter assay was used to confirm the downstream targets of miR-223-5p. Results: A total of 39 DE-miRNAs were identified between TAO patients and normal controls, of which, miR-223-5p was one of the most significantly up-regulated miRNAs. TAO plasma-derived exosomes or miR-223-5p mimics inhibited cell viability of HVSMCs and promoted cell apoptosis. The pro-apoptotic effect of TAO plasma-derived exosomes was alleviated by miR-223-5p inhibitor. Additionally, the expressions of VCAM1 and IGF1R were down-regulated by exosomes and miR-223-5p mimics, and were abrogated by miR-223-5p inhibitor. Dual-luciferase report showed that VCAM1 was the target of miR-223-5p. Conclusions: Our findings imply that circulating exosomal miR-223-5p may play an essential role in the pathogenesis of TAO, and provide a basis for miR-6515-5p/VCAM1 as novel therapeutic targets and pathways for TAO treatment.